Funder: Advanced Research Projects Agency for Health (ARPA-H)
Due Dates: December 12, 2024 (Updated Response Date) | April 30, 2025 (Updated Inactive Date)
Funding Amounts: Total funding approximately $50 million; awarded via cooperative agreements.
Summary: Supports innovative solutions for lymphatic system interventions and drug development under the GLIDE program.
Key Information: Open to a broad range of applicants including individuals, nonprofits, academic institutions, and for-profit organizations; emphasizes high-risk, high-reward biomedical research with transformative potential.